Antikörper gegen Humanes Immundefizienzvirus Typ 1 P24 und Typ 2 P26 und Verwendungen davon

Details

Veröffentlichungs-Nr.

EP4733318

Anmeldetag

24. Oktober 2025

Veröffentlichung

29. April 2026

Rechtsraum

EP

IPC

(LOU SHENG C et al.)(AKZO NV et al.)(ABBOTT LAB et al.) [Y] 1-15

Abstract

The present disclosure relates to the field of biomedical technology, and specifically to an antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof. The present disclosure provides an antibody or antigen-binding fragment thereof capable of specifically binding to human immunodeficiency virus type 1 p24 protein and human immunodeficiency virus type 2 p26 protein. The present disclosure also provides an antibody pair, kit and related uses thereof. Utilizing the antibody pair in immunoassays enables the simultaneous detection of HIV-1 p24 and HIV-2 p26 antigens, with the advantage of a lower limit of detection (LOD).

Anmelder

Firmen

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Hytest Ltd.

Land

🇨🇳 China